2325: Yunkang Group Limited - Summary | Jitta

Yunkang Group Limited

HKG:2325

Price
HK$0.74
Loss Chance
46.1%
3.62JITTA SCORE
42.02%Under Jitta Line
Jitta Ranking
49 / 233
318 / 2,517
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (66)
Financial Strength (68)
Return to Shareholders (17)
Competitive Advantage (27)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Share RepurchaseEvery Year
Revenue and EarningEarning loss detected in 2024
Operating MarginInconsistent
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.62
42.02%
3.82
206.93%
Health Care Services
5.40
18.15%
5.50
32.09%
3.21
100.00%
COMPANY DESCRIPTION
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests; and genetic reproduction and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides technology platforms, including AI + healthcare; high-throughput sequencing technology platform; PCR technology platform; digital pathology remote diagnosis platform; and other technology platforms. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.